Author:
Smith Meredith Y.,Bailey J. Elise,Woody George E.,Kleber Herbert D.
Subject
Psychiatry and Mental health,Clinical Psychology,General Medicine,Medicine (miscellaneous)
Reference17 articles.
1. Medicines and the drug control treaties: is buprenorphine for opioid addiction at risk of being lost?
2. Drug Addiction Treatment Act of 2000, Public Law 106–310, Title XXXV (DA. T. A., 2000). Federal Food, Drug, and Cosmetic Act. (Act) 21 U.S.C. § 360, Section 510.
3. U.S. Food and Drug Administration. FDA Talk Paper: Subutex®and Suboxone®approved to treat opioid dependence. T08–38; October, 8. 2002. Available at:http://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01165.hjtml. Last accessed: November 15, 2006.
4. Behavioral pharmacology of buprenorphine, with a focus on preclinical models of reward and addiction
5. French Field Experience with Buprenorphine
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Is daily supervised buprenorphine-naloxone dosing necessary?;BMJ;2022-08-16
2. References;Substance Use Disorders;2020-09-17
3. Treatment of Substance Use Disorders;Substance Use Disorders;2020-09-17
4. Tranquilizers and Sedative Use Disorders;Substance Use Disorders;2020-09-17
5. Opioid Use Disorders;Substance Use Disorders;2020-09-17